Laurion Capital Management’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-14,617
| Closed | -$1.39M | – | 971 |
|
|
2020
Q2 | $1.39M | Buy |
+14,617
| New | +$1.39M | 0.02% | 161 |
|
|
2020
Q1 | – | Sell |
-13,127
| Closed | -$696K | – | 814 |
|
|
2019
Q4 | $696K | Buy |
13,127
+6,127
| +88% | +$325K | 0.01% | 280 |
|
|
2019
Q3 | $277K | Sell |
7,000
-17,219
| -71% | -$681K | ﹤0.01% | 488 |
|
|
2019
Q2 | $995K | Buy |
+24,219
| New | +$995K | 0.01% | 276 |
|
|
2017
Q4 | – | Sell |
-142,630
| Closed | -$5.32M | – | 1452 |
|
|
2017
Q3 | $5.32M | Buy |
+142,630
| New | +$5.32M | 0.02% | 186 |
|
|
2017
Q1 | – | Sell |
-202,738
| Closed | -$5.17M | – | 1156 |
|
|
2016
Q4 | $5.17M | Sell |
202,738
-487,262
| -71% | -$12.4M | 0.05% | 89 |
|
|
2016
Q3 | $25M | Buy |
+690,000
| New | +$25M | 0.23% | 21 |
|